Information Provided By:
Fly News Breaks for February 3, 2020
Feb 3, 2020 | 08:15 EDT
Needham analyst Stephen Unger raised his price target on Danaher to $187 and kept his Buy rating after its Q4 earnings beat and above-consensus Q1 guidance, with core revenue growth remaining "solid". The analyst adds that the company's FY20 EPS guidance of $4.80-$4.90 - below the expected $5.34 - do not reflect the 60c accretion from GE Biopharma business upon the deal's closing, though he warns that the outlook also does not reflect the potential headwinds from the recent China coronavirus outbreak.
News For DHR From the Last 2 Days
There are no results for your query DHR